RRM2 can be used as a prognostic biomarker for a variety of cancer types, such as colon cancer and breast cancer [40–42], and overexpression of RRM2 also stimulates the migration, invasion, and proliferation of many other solid tumor cells. This evidence concerns the gene RRM2 and cancer.